What intravenous medications are recommended for an adult with acute severe dizziness and associated nausea or vomiting?

IV Medication for Acute Severe Dizziness with Nausea/Vomiting

For acute severe dizziness with associated nausea or vomiting, use IV ondansetron (4-8 mg) as first-line therapy to control nausea, but avoid routine use of vestibular suppressants (antihistamines or benzodiazepines) for the dizziness itself unless symptoms are refractory.

Primary Treatment Approach

The evidence strongly supports a symptom-targeted strategy rather than blanket vestibular suppression:

For Nausea/Vomiting Control

• IV ondansetron (4-8 mg) is the preferred first-line antiemetic 1
  • Safe and effective with minimal side effects
  • No sedation or akathisia risk
  • Works via 5-HT3 receptor antagonism at the central emetic center
  • Demonstrated efficacy in prehospital and emergency settings 2, 3

Alternative Antiemetics (if ondansetron fails or is unavailable)

• IV metoclopramide (10-20 mg): dopamine antagonist with prokinetic effects
• IV/IM promethazine (12.5-25 mg): more sedating, higher side effect profile but more effective for vertigo reduction 4
  • Caution: risk of vascular damage with IV administration
  • More effective than ondansetron for vertigo itself, but worse side effect profile
• IV prochlorperazine: effective but monitor for akathisia (can occur up to 48 hours post-dose) 5, 3

Critical Guideline Recommendations

Vestibular suppressants (antihistamines, benzodiazepines) should NOT be routinely used 1:

• No evidence they effectively treat the underlying vestibular pathology
• They interfere with central vestibular compensation
• Only justified for short-term management of severe vegetative symptoms (nausea/vomiting) in severely symptomatic patients
• Common agents include meclizine, diphenhydramine, diazepam, clonazepam—all discouraged for routine use

Clinical Algorithm

1. Assess severity of nausea/vomiting:

   • If severe → IV ondansetron 4-8 mg immediately
   • If refractory → add IV metoclopramide or consider promethazine

2. Evaluate for underlying cause:

   • BPPV (most common): positional trigger, brief episodes—treat with repositioning maneuvers (Epley), NOT medications 1
   • Vestibular neuritis: acute persistent vertigo—brief vestibular suppressants acceptable initially, then taper quickly 6
   • Central causes: require neuroimaging if atypical features present

3. Adjunctive therapy:

   • IV hydration if dehydrated
   • Lorazepam 0.5-2 mg IV/SL only if severe anxiety component 5
   • Avoid first-generation antihistamines (diphenhydramine)—can worsen hypotension 7

Important Caveats

• Dexamethasone IV does NOT improve nausea or dizziness in vestibular neuritis despite theoretical benefits 8
• Promethazine is more effective than ondansetron for vertigo reduction but has significantly more side effects (sedation, hypotension risk) 4
• Around-the-clock dosing is superior to PRN for breakthrough symptoms 5
• If patient cannot tolerate oral route due to vomiting, IV/IM routes are essential 5
• Reassess within 1 month to confirm symptom resolution 1

Pitfalls to Avoid

• Don't use vestibular suppressants as primary treatment—they delay compensation and have no evidence for efficacy in BPPV 1
• Don't use promethazine IV without caution due to vascular injury risk
• Don't forget to monitor for akathisia with metoclopramide/prochlorperazine (treat with diphenhydramine 25-50 mg IV if occurs) 3
• Don't assume all dizziness needs medication—BPPV requires physical maneuvers, not drugs 1

The key principle: treat the nausea/vomiting symptomatically with ondansetron, but address the underlying vestibular pathology with appropriate non-pharmacologic interventions rather than vestibular suppressants.